Cite
HARVARD Citation
Brunner, A. et al. (2019). Isocitrate dehydrogenase 1 and 2 mutations, 2‐hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia. Cancer. 125 (4), pp. 541-549. [Online].